Related content

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

By Belpomme D.   Krakowski I.   Beauduin M.   Petit T.   Canon J.L.   Janssens J.   Gauthier S.   De Pauw A.   Moreau V.   Kayitalire L.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 32-38

Elsevier

Access to resources Recommend Favorite

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study

By Furuse Junji  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 849-855

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

By Venturini M.   Bighin C.   Monfardini S.   Cappuzzo F.   Olmeo N.   Durando A.   Puglisi F.   Nicoletto O.   Lambiase A.   Mastro L.  

Breast Cancer Research and Treatment, Vol. 95, Iss. 1, 2006-01 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study - docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

By Rougier P.   Adenis A.   Ducreux M.   de Forni M.   Bonneterre J.   Dembak M.   Clouet P.   Lebecq A.   Baille P.   Lefresne-Soulas F.   Blanc C.   Armand J.P.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 1016-1025

Elsevier

Access to resources Recommend Favorite

A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer

By Dittrich Christian   Solska Ewa   Manikhas Alexey   Eniu Alexandru   Tjulandin Sergei   Anghel Rodica   Musib Luna   Frimodt-Moller Bente   Liu Yushan   Krejcy Kurt   Láng István  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 309-316

Informa Healthcare

Access to resources Recommend Favorite